Abstract:The advantages of femoral canulation rather than conventional central connections in lung transplantation procedures led to an undisturbed operative field. A significantly higher blood product amount was required in ECMO patients, which might lead to increased infection and mortality rates. CPB, obviously, should remain the standard support technique if extracorporeal circulation is required in lung transplantation surgery.
“…Preliminary data regarding the utility of ECMO relative to CPB is varied. A study by Bittner and colleagues 16 in 2006 suggested that ECMO use led to higher rates of blood product transfusions, as well as worse 1-year survivals. 16 A more recent report from Ius and coworkers 15 in 2012 demonstrated lower blood product transfusion rates and improved survivals at 3, 9, and 12 months in the ECMO group relative to the CPB group.…”
Section: Discussionmentioning
confidence: 97%
“…A study by Bittner and colleagues 16 in 2006 suggested that ECMO use led to higher rates of blood product transfusions, as well as worse 1-year survivals. 16 A more recent report from Ius and coworkers 15 in 2012 demonstrated lower blood product transfusion rates and improved survivals at 3, 9, and 12 months in the ECMO group relative to the CPB group. 15 With a recent paradigm shift at our institution from intraoperative CPB to ECMO, we sought to compare intraoperative and postoperative outcomes between the 2 groups.…”
Section: Discussionmentioning
confidence: 97%
“…13,14 Because of the potential pulmonary complications of CPB and the widespread use of ECMO, several lung transplant centers have begun to use intraoperative ECMO instead of CPB, with mixed results. [15][16][17] ECMO has potential advantages in that there is no venous reservoir or cardiotomy suction, leading to lessened blood-air interface, and it also allows an easy transition to postoperative ECMO for cardiopulmonary support if necessary. Beginning in 2011, our transplant center began incorporating ECMO intraoperatively in lieu of CPB when feasible.…”
Relative to CPB, the ECMO group required fewer transfusions and had less bleeding, fewer reoperations, and less primary graft dysfunction. There were no statistically significant survival differences at 30 days or 1 year.
“…Preliminary data regarding the utility of ECMO relative to CPB is varied. A study by Bittner and colleagues 16 in 2006 suggested that ECMO use led to higher rates of blood product transfusions, as well as worse 1-year survivals. 16 A more recent report from Ius and coworkers 15 in 2012 demonstrated lower blood product transfusion rates and improved survivals at 3, 9, and 12 months in the ECMO group relative to the CPB group.…”
Section: Discussionmentioning
confidence: 97%
“…A study by Bittner and colleagues 16 in 2006 suggested that ECMO use led to higher rates of blood product transfusions, as well as worse 1-year survivals. 16 A more recent report from Ius and coworkers 15 in 2012 demonstrated lower blood product transfusion rates and improved survivals at 3, 9, and 12 months in the ECMO group relative to the CPB group. 15 With a recent paradigm shift at our institution from intraoperative CPB to ECMO, we sought to compare intraoperative and postoperative outcomes between the 2 groups.…”
Section: Discussionmentioning
confidence: 97%
“…13,14 Because of the potential pulmonary complications of CPB and the widespread use of ECMO, several lung transplant centers have begun to use intraoperative ECMO instead of CPB, with mixed results. [15][16][17] ECMO has potential advantages in that there is no venous reservoir or cardiotomy suction, leading to lessened blood-air interface, and it also allows an easy transition to postoperative ECMO for cardiopulmonary support if necessary. Beginning in 2011, our transplant center began incorporating ECMO intraoperatively in lieu of CPB when feasible.…”
Relative to CPB, the ECMO group required fewer transfusions and had less bleeding, fewer reoperations, and less primary graft dysfunction. There were no statistically significant survival differences at 30 days or 1 year.
“…The impact of ECMO on blood loss needs to be established. There are studies that suggest ECMO might provide a better view in the operation field for the surgeon, and therefore contribute to less transfusions (29,30), however, there are also contradictory studies that held ECMO to be responsible for blood loss and blood transfusion requirements (31), while other studies do not show any difference between CPB and ECMO (32). Hence, the role of extracorporeal circulation support in blood loss in lung transplantations is not yet completely understood.…”
Section: Predictors Of Blood Loss During Lung Transplantationmentioning
Lung transplantation is an established therapeutic procedure for end stage lung diseases. Its success may be impaired by perioperative complications. Intraoperative blood loss and the resulting blood transfusion are among the most common complications. The various factors contributing to increased blood loss during lung transplantation are only scarcely investigated and not yet completely understood. This is in sharp contrast to other surgical fields, as in orthopedic surgery, liver transplantation and cardiac surgery the contributors to blood loss are well identified. This narrative review article aims to highlight the acknowledged factors influencing blood loss in lung transplantation (such as double vs. single lung transplant) and to discuss potential factors that may be of interest for further research or helpful to develop strategies targeting risk factors in order to minimize blood loss during lung transplantation and finally improve patient outcome.
“…However, they use ECMO on a selective basis and more than 50% of patients were performed LTx without cardiopulmonary support with excellent outcomes (17,18). However, our institute has limited experience and lower annual volume.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.